NIH-funded research R01 grant

Using a mobile app to help men with HIV and stimulant use disorders

Official title: reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)

Funded at University of Miami School of Medicine · NIH-10689982 · Data updated 2026-11-12

This study is looking at whether a mobile app called reSET can help men who have sex with men and are living with HIV reduce their use of stimulants while they go through a 12-week online treatment program.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startSeptember 1, 2022
Project endJuly 31, 2028
Funding year2023
Award (this year)$990,189
NIH project number5R01DA055563-02
Project IDNIH-10689982 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are men who have sex with men, are living with HIV, and have a primary diagnosis of stimulant use disorder.

Less likely to help

Patients who do not have a stimulant use disorder or are not living with HIV may not receive any benefit from this research.

What this research studies

This research investigates the effectiveness of reSET, a mobile therapeutic software, in treating stimulant use disorders among men who have sex with men (MSM) living with HIV. The study will involve a randomized controlled trial where participants will engage in a 12-week virtual treatment program while receiving antiretroviral therapy. The goal is to assess whether this innovative approach can help reduce stimulant use and improve health outcomes for this high-risk population. Participants will be recruited from the AIDS Healthcare Foundation and will include a diverse group of racial and ethnic backgrounds.

Why it matters

Potential benefit: If successful, this research could provide a new, effective treatment option for MSM living with HIV who struggle with stimulant use, ultimately improving their health and reducing HIV transmission.

How similar studies have gone: While reSET has shown efficacy in other settings, this specific application in HIV care is novel and has not been previously tested.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: Szapocznik, Jose — University of Miami School of Medicine
  • Study coordinator: Szapocznik, Jose

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.